Latest news with #TheJoint
Yahoo
22-05-2025
- Business
- Yahoo
The Joint Corp. Announces Christopher M. Grandpre Elected as Director
- Franchise and investment banking expert strengthens the board - SCOTTSDALE, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network dedicated to revolutionizing access to chiropractic care and building a leading wellness franchise with a strong business model, announced Christopher M. Grandpre has been elected as a director to help enable the company in achieving its goals of long-term growth in net new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA. Lead Director Matthew E. Rubel stated, 'Chris is a stellar board member and franchise expert. As Chairman of Empower Brands, he has worked with the executive team to continue building and growing the leading commercial and residential services multi-brand franchise platform. Blending his experience as an entrepreneur, large multi-concept franchisor, CEO and mergers and acquisitions investment banker, Chris provides unique perspective and guidance. I look forward to his contributions to The Joint.' Grandpre said, 'I am excited to work with Sanjiv, Matt and the entire leadership and board to help the team and franchisees achieve their goals and the company to reach its full potential.' The Joint Corp. extends its sincere gratitude to Glenn Krevlin for his six years of dedicated service to the board. Glenn did not stand for re-election, and Christopher M. Grandpre has filled the vacancy, maintaining the board at seven directors. About Christopher M. Grandpre Christopher M. Grandpre has over 30 years of experience leading multi-branded franchise companies and in M&A investment banking. As an Operating Partner with MidOcean Partners, he assists in executing an investment thesis targeting franchised consumer businesses. Grandpre has served as the chairman of Empower Brands, a franchisor of ten residential and commercial service franchise systems with sales in excess of $1.5 billion since 2022. Empower Brands was formed when MidOcean Partners acquired Outdoor Living Brands and merged it with LYNX Franchising. In this role, he assists the senior leadership team with strategy and evaluation of additional franchise businesses to acquire or incubate. Grandpre founded Outdoor Living Brands in 2008 after leading the turnaround of and then purchasing the Archadeck franchise. As CEO and chairman, he grew Outdoor Living Brands through acquisitions and incubation and operated five consumer service franchises. Prior, Grandpre served in executive roles at National Restorations, Matrix Capital Markets Group and BB&T Capital Markets. He started his career in management consulting with what is now Accenture and provided M&A advisory services to privately held businesses. Grandpre holds a Bachelor of Science in Business Administration with a concentration in Finance from University of Notre Dame and a Masters in Business Administration from Virginia Commonwealth University. About The Joint Corp. (NASDAQ: JYNT) The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation's largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. Headquartered in Scottsdale, with over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times' annual 'Top 400' and 'Fast & Serious' list of 40 smartest growing brands. Entrepreneur named The Joint 'No. 1 in Chiropractic Services,' and is regularly ranked on the publication's 'Franchise 500,' the 'Fastest-Growing Franchises,' the 'Best of the Best' lists, as well as its 'Top Franchise for Veterans' and 'Top Brands for Multi-Unit Owners.' SUCCESS named the company as one of the 'Top 50 Franchises' in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit To learn about franchise opportunities, visit Business Structure The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices. Media Contact:Margie Wojciechowski, The Joint Corp., Investor Contact:Kirsten Chapman, Alliance Advisors IR, 415-433-3777, thejointinvestor@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Ottawa Citizen
05-05-2025
- Health
- Ottawa Citizen
Community Builders: Ride for Dad launch party
With engines revving and hearts full, hundreds of riders are expected to take to the streets of Ottawa on June 7 for the annual Motorcycle Ride for Dad, a fundraising and awareness event focused on the fight against prostate cancer. Article content A 25th anniversary launch party for Ottawa's Ride for Dad was held Thursday, May 1, at The Joint inside Rideau Carleton Casino, Future Hard Rock Ottawa, bringing together riders, volunteers and supporters ahead of the ride. Article content Article content The event has raised more than $8 million locally since its inception. Proceeds support research and awareness campaigns through the Prostate Cancer Fight Foundation, the charitable arm of Ride for Dad. Article content Michael Anderson, Ottawa chapter chair, said the ride is personal for many. Anderson lost his father to the disease in 2021. 'I don't think that anybody should have to go through the pain that my mom's gone through, that my son's gone through, that my wife's gone through, that I've gone through,' he said after speaking about his father's battle. His father went through more than 40 rounds of radiation. He had a glimpse of hope through a moment of remission only for cancer to return in the form of bone cancer. Article content For one mother and daughter duo, the ride is both tribute and mission. Article content 'I didn't even know what prostate cancer was until my husband was diagnosed,' said Suzanne McCann, who lost her husband in December 2014. 'We thought it was an old man's disease.' Article content Article content Her daughter, Stephanie Giroux, now the event's logistics coordinator, said this year feels like a milestone. 'It's a celebration of all the work we've done over the years and all the money we've raised and donated for research and awareness,' she said. Article content Article content Article content Article content Article content Article content Article content
Yahoo
24-04-2025
- Business
- Yahoo
The Joint Corp. to Host Conference Call on Thursday, May 8th to Discuss First Quarter 2025 Results
SCOTTSDALE, Ariz., April 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) a national operator, manager, and franchisor of chiropractic clinics, announced it will report its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. President and CEO Sanjiv Razdan and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing (833) 630-0823 or (412) 317-1831 and ask to be joined into the 'The Joint' call approximately 15 minutes prior to the start time. The live webcast of the call with accompanying slide presentation can be accessed in the IR events section and available for approximately one year. An audio archive can be accessed for one week by dialing (877) 344-7529 or (412) 317-0088 and entering conference ID 9867193. About The Joint Corp. The Joint Corp. revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation's largest franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. Headquartered in Scottsdale and with over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times' annual "Top 400" and "Fast & Serious" list of 40 smartest growing brands. Entrepreneur named The Joint "No. 1 in Chiropractic Services," and is regularly ranked on the publication's "Franchise 500," the "Fastest-Growing Franchises," the "Best of the Best" lists, as well as its "Top Franchise for Veterans" and "Top Brands for Multi-Unit Owners." SUCCESS named the company as one of the "Top 50 Franchises" in more information, visit To learn about franchise opportunities, visit Business Structure The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices. Media Contact:Margie Wojciechowski, The Joint Corp., Investor Contact:Kirsten Chapman, Alliance Advisors IR, 415-433-3777, thejointinvestor@ in to access your portfolio
New York Times
24-04-2025
- Entertainment
- New York Times
‘Cheech and Chong's Last Movie' Review: Rolling Another One for the Road
It is not quite accurate to state that had recreational marijuana use been legal in the early 1970s, the comedy team of Cheech Marin and Tommy Chong would not have had careers. As the new documentary 'Cheech and Chong's Last Movie' details, they had rather relatively lucrative gigs before the rise of the counterculture. But when they brought stoner characters into their act, it propelled them even, well, higher. 'Cheech and Chong's Last Movie,' directed by David Bushell, features the two comedians ruminating on their careers and friendship. They do so both in separate talking-head segments and sitting together in the front seat of a vintage roadster in search of a site called 'The Joint.' The first segments are more or less extemporaneous interviews, while the scenes in the roadster are scripted. The emotions they perform, however, feel genuine. Bushell has an archive of vintage audio and visual footage to buttress an already incredible narrative. Tommy Chong was born in Canada, but Richard Marin, who was known as Cheech, moved there in the 1960s to avoid the Vietnam War draft. Both were keen on pursuing music careers before they met in an improv theater group in Vancouver. The movie delves so deeply into their pasts that 'Cheech and Chong,' their 1971 blockbuster debut comedy album, doesn't come up until an hour into the movie. And yet the documentary doesn't quite cover everything — their collaborations with Joni Mitchell and Martin Scorsese go unmentioned, for example. This is still a rollicking account that will make even non-herbally-inclined viewers root for the fellows.
Yahoo
14-03-2025
- Business
- Yahoo
The Joint Corp (JYNT) Q4 2024 Earnings Call Highlights: Strong Sales Growth Amidst Economic ...
System-wide Sales: Increased to $530.3 million in 2024, up 9% in Q4 2024 compared to 8% in Q3 2024. System-wide Comp Sales: 6% for all clinics opened 13 months in Q4 2024, compared to 4% in Q3 2024. Revenue from Continuing Operations: Increased 14% in Q4 2024, up from 10% in Q3 2024. Consolidated Adjusted EBITDA: $3.3 million for Q4 2024 and $11.4 million for the full year 2024. Patient Adjustments: 14.7 million performed in 2024, an 8% increase from 2023. Unique Patients Treated: 1.9 million in 2024, with 957,000 new to The Joint. Franchise Clinics: 57 opened, 3 refranchised, and 18 closed in 2024. Total Clinics: 967 at year-end 2024, with 842 being franchise clinics. Net Income from Continuing Operations: $986,000 or $0.06 per diluted share in Q4 2024. Unrestricted Cash: $25.1 million at December 31, 2024, compared to $18.2 million at December 31, 2023. 2025 Guidance: System-wide sales expected between $550 million and $570 million; consolidated adjusted EBITDA between $10 million and $11.5 million. Warning! GuruFocus has detected 5 Warning Signs with JYNT. Release Date: March 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. The Joint Corp (NASDAQ:JYNT) reported a 9% increase in system-wide sales for 2024, reaching $530.3 million, indicating strong sales momentum. The company served close to 1 million new patients in 2024, showcasing its significant impact in the chiropractic care industry. The Joint Corp (NASDAQ:JYNT) plans to expand its clinic network, with potential for an additional 1,000 clinics in the US alone, highlighting growth opportunities. The company is transitioning to a pure-play franchisor model, which is expected to improve profitability and reduce overhead costs. The Joint Corp (NASDAQ:JYNT) is focusing on dynamic revenue management and digital marketing to drive revenue growth and enhance patient engagement. The company is facing consumer headwinds and inconsistencies in execution, including variability in patient experience and inefficiencies in marketing. There are challenges in retaining doctors of chiropractic and addressing lower volume clinics, impacting overall performance. The time for new clinics to breakeven has extended, with more clinics comping negative than desired. Economic headwinds, stubborn inflation, and volatile consumer sentiment are expected to impact the beginning of 2025. Franchise license sales and clinic openings are likely to be less in 2025 compared to 2024 due to refranchising efforts. Q: Can you comment on the potential impact of slower consumer behavior in Q1 and how we might model the quarterly progression this year? A: Sanjiv Razdan, President and CEO, noted that consumers are responding to inflation and macroeconomic uncertainty, which affects their target demographic with household incomes between $50,000 and $100,000. Jake Singleton, CFO, added that the sales cadence is expected to be similar to previous years, with major promotions driving incremental sales in Q4. Q: What are the current trends in patient retention, churn, and attrition? A: Jake Singleton, CFO, stated that conversion rates ended strong in 2024, with attrition remaining flat. The company has implemented fringe pricing increases, which have driven increased conversion to wellness plans. January saw a slight uptick in attrition, typical for the period, but it leveled off in February. Q: How many corporate clinics are under letters of intent (LOI) for refranchising, and what is the timeline for this process? A: Sanjiv Razdan, President and CEO, confirmed that all 125 corporate clinics are intended for refranchising, with the vast majority under LOI negotiations. The company aims to complete this process closer to the first half of the year. Q: Can you provide insights into the valuation of the corporate clinics being refranchised? A: Jake Singleton, CFO, explained that most bidders are evaluating the clinics based on a multiple of EBITDA, adjusted for franchise-centric EBITDA, which includes royalty streams. The clinics are marketed in larger clusters, considering a slight outside G&A burden. Q: How should we think about customer acquisition costs and the leverage points for future revenue growth? A: Jake Singleton, CFO, highlighted that the company increased media spend to support marketing campaigns and is onboarding a new marketing agency, which involves initial transition costs. The focus is on organic lead generation, with paid media dollars being used to address new patient pressure. Q: What is the current pricing strategy, and how many customers are on legacy pricing plans? A: Jake Singleton, CFO, noted that 80% of active members are on the standard rate, with 20% on legacy rates. The company is exploring dynamic revenue management to optimize pricing without creating a value problem, testing pricing models in different markets. Q: What is the timeline for introducing new services and retail products? A: Sanjiv Razdan, President and CEO, stated that the focus for 2025 is on strengthening the core business and reigniting growth. New services and retail products are part of the Joint 3.0 phase, expected to begin 12 to 18 months later, with exploration ongoing this year. Q: What percentage of royalty and service fees do you expect from the $550 million to $570 million system-wide sales in 2025? A: Jake Singleton, CFO, explained that 2025 is a transition year with corporate clinics contributing to GAAP revenues for part of the year. The royalty structure is approximately 10% to 10.5%, including royalties, NMF contributions, and technology fees. The focus is on reducing G&A expenses to improve profitability. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
